How the big domestic pharmas have performed since the mid-October highs
Percentages are dividend-adjusted as some pharmas including PFE have had ex-dividend dates since mid-October while others have not:
1) Down 04.8%. JNJ ($72.52 to $69.07).. #5 in overall 2012 performance.
2) Down 08.4%. PFE ($25.82 to $23.66). #4 in overall 2012 performance.
3) Down 10.4%. BMY ($34.38 to $30.81). #6 in overall 2012 performance.
4) Down 10.8%. MRK ($47.96 to $42.80). #1 in overall 2012 performance.
5) Down 12.4%. ABT ($72.13 to $63.20). #2 in overall 2012 performance.
6) Down 13.8%. LLY ($53.32 to $45.96). #3 in overall 2012 performance..
Down 10.1%. Average of the six domestic pharmas
Down 7.4%. S & P 500 (1.461 to 1,353)
Down 7.5%. Dow 30 (13,557 to 12.542).
Sentiment: Buy